Sugi Predict

Sugi Predict / Compounds / SCHEMBL1833147

SCHEMBL1833147

SCHEMBL1833147

C[C@H](NC(=O)Oc1ccccc1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A3 P43003 1/20 0.58
▸ ALDH1A1 P00352 5/20 0.51
▸ GAA P10253 3/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ CYP1A2 P05177 1/20 0.50
▸ MAPT P10636 3/20 0.49
▸ HSP90AA1 P07900 1/20 0.47
▸ FAAH O00519 1/20 0.47
▸ CCNE1 P24864 1/20 0.46
▸ CDK2 P24941 1/20 0.46
▸ CDK5 Q00535 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ THRB P10828 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1837626 1.00 SLC1A3 (0.58) SLC1A3ALDH1A1GAAMEN1KMT2A
SCHEMBL27716144 1.00 SLC1A3 (0.58) SLC1A3ALDH1A1GAAMEN1KMT2A
SCHEMBL11823050 0.86 SMN1; SMN2 (0.57) SLC1A3ALDH1A1GAANPC1RAB9A
SCHEMBL27406024 0.86 SLC1A3 (0.55) SLC1A3ALDH1A1GAAMEN1KMT2A
SCHEMBL23423134 0.86 MAPK1 (0.56) SLC1A3ALDH1A1GAAMEN1KMT2A
SCHEMBL1895598 0.85 SLC1A3 (0.57) SLC1A3ALDH1A1GAAMEN1KMT2A
SCHEMBL1849668 0.83 SLC1A3 (0.56) SLC1A3ALDH1A1GAAMEN1KMT2A
SCHEMBL16173967 0.83 ALDH1A1 (0.50) SLC1A3ALDH1A1GAAMEN1KMT2A
SCHEMBL3363885 0.82 SLC1A3 (0.69) SLC1A3ALDH1A1GAAMEN1KMT2A
SCHEMBL1953003 0.82 SLC1A3 (0.69) SLC1A3ALDH1A1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0357750-B1 URETHANE-PROTECTED AMINO ACID-N-CARBOXYANHYDRIDES BIORESEARCH INC (US) 1994-07-13 — — EP claimed
WO-2024043313-A1 REVERSIBLE THERMOCHROMIC COMPOSITION, MICROENCAPSULATED PIGMENT USING SAID REVERSIBLE THERMOCHROMIC COMPOSITION, WRITING TOOL, AND TOY 三菱ケミカル株式会社 2024-02-29 — — WO disclosed
WO-2024043313-A1 REVERSIBLE THERMOCHROMIC COMPOSITION, MICROENCAPSULATED PIGMENT USING SAID REVERSIBLE THERMOCHROMIC COMPOSITION, WRITING TOOL, AND TOY 三菱ケミカル株式会社 2024-02-29 — — WO disclosed
CN-110546135-B Method for producing isocyanate 旭化成株式会社 2021-12-14 — — CN disclosed
CN-112438905-B Moisturizing and skin-brightening composition and application thereof 澳思美日用化工（广州）有限公司 2021-09-07 — — CN disclosed
US-10968168-B2 Isocyanate production method ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-04-06 — — US disclosed
EP-3626705-B1 ISOCYANATE PRODUCTION METHOD ASAHI CHEMICAL IND (JP) 2021-03-24 — — EP disclosed
CN-112438905-A Moisturizing and skin-brightening composition and application thereof 澳思美日用化工（广州）有限公司 2021-03-05 — — CN disclosed
US-20200115327-A1 ISOCYANATE PRODUCTION METHOD ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-04-16 — — US disclosed
CN-110546135-A Method for producing isocyanate ASAHI CHEMICAL IND 2019-12-06 — — CN disclosed
EP-2322515-B1 A process for the preparation of an N-carboxy amino acid anhydride or an amino acid carbamate JSR CORP (JP) 2016-04-20 — — EP disclosed
US-8748650-B2 Method for production of N-carboxy amino acid anhydride and amino acid carbamate compound JSR CORPORATION (JP) 2014-06-10 — — US disclosed
US-20110152561-A1 METHOD FOR PRODUCTION OF N-CARBOXY AMINO ACID ANHYDRIDE AND AMINO ACID CARBAMATE COMPOUND JSR CORPORATION (JP) 2011-06-23 — — US disclosed
EP-2322515-A1 N-CARBOXY AMINO ACID ANHYDRIDE AND AMINO ACID CARBAMATE COMPOUND PRODUCTION METHOD JSR Corporation (JP) 2011-05-18 — — EP disclosed
CN-101227885-A Wrinkle preventing/improving agent SHISEIDO CO LTD (JP) 2008-07-23 — — CN disclosed
EP-1338588-B1 METHOD OF RESOLVING OPTICAL ISOMERS OF AMINO ACID DERIVATIVE TOKUYAMA CORP (JP) 2007-09-26 — — EP disclosed
US-7199264-B2 Method of resolving optical isomers of amino acid derivative TOKUYAMA CORPORATION (JP) 2007-04-03 — — US disclosed
US-20040102646-A1 Method of resolving optical isomers of amino acid derivative TOKUYAMA CORPORATION (JP) 2004-05-27 — — US disclosed
EP-1338588-A1 METHOD OF RESOLVING OPTICAL ISOMERS OF AMINO ACID DERIVATIVE TOKUYAMA CORPORATION (JP) 2003-08-27 — — EP disclosed
EP-0854862-B1 PROCESS FOR THE PREPARATION OF AN ACTIVATED AMINO ACID ABBOTT LAB (US) 2001-10-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102646-A1 Method of resolving optical isomers of amino acid derivative ALAD, AAAS, BCAT1 SLC1A3 105/4885ALDH1A1 3448/4885GAA 2087/4885
US-20200115327-A1 ISOCYANATE PRODUCTION METHOD IDH3A, ALKBH3, CPS1 SLC1A3 4750/4885ALDH1A1 1502/4885GAA 1174/4885
US-10968168-B2 Isocyanate production method IDH3A, ALKBH3, CPS1 SLC1A3 4750/4885ALDH1A1 1502/4885GAA 1174/4885
US-20110152561-A1 METHOD FOR PRODUCTION OF N-CARBOXY AMINO ACID ANHYDRIDE AND AMINO ACID CARBAMATE COMPOUND CA7, CPS1, DNPEP SLC1A3 73/4885ALDH1A1 3310/4885GAA 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.